| dc.contributor.author | Ozden, Muge G. | |
| dc.contributor.author | Ozdemir, Hilal | |
| dc.contributor.author | Senturk, Nilgun | |
| dc.date.accessioned | 2020-06-21T12:18:29Z | |
| dc.date.available | 2020-06-21T12:18:29Z | |
| dc.date.issued | 2020 | |
| dc.identifier.issn | 1396-0296 | |
| dc.identifier.issn | 1529-8019 | |
| dc.identifier.uri | https://doi.org/10.1111/dth.13229 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/10215 | |
| dc.description | WOS: 000510757800001 | en_US |
| dc.description | PubMed: 31965687 | en_US |
| dc.description.abstract | We report a retrospective analysis the efficacy of high-dose intravenous immunoglobulins on 9 patients with Livedoid vasculopathy for whom resistant to immunosuppressants plus anticoagulants or could not be prescribed. Intravenous immunoglobulins were used 2 g/kg per month in these patients. The treatment induced stabilization of the disease and all patients demonstrated improvement with IVIg. Complete and partial clinical response was achieved in 6 and 3 patients respectively. | en_US |
| dc.language.iso | eng | en_US |
| dc.publisher | Wiley | en_US |
| dc.relation.isversionof | 10.1111/dth.13229 | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | intravenous immunoglobuline | en_US |
| dc.subject | livedoid vasculopathy | en_US |
| dc.subject | therapy-systemic | en_US |
| dc.title | Intravenous immunoglobulin in resistant livedoid vasculopathy: Analysis of a case series | en_US |
| dc.type | article | en_US |
| dc.contributor.department | OMÜ | en_US |
| dc.identifier.volume | 33 | en_US |
| dc.identifier.issue | 2 | en_US |
| dc.relation.journal | Dermatologic Therapy | en_US |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
